Voloridge Investment Management
IMCR icon

Voloridge Investment Management’s Immunocore IMCR Stock Holding History

Voloridge Investment Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,492
Closed -$588K – 935
2026
Q1 		$588K Sell
19,492
-8,672
-31% -$281K ﹤0.01% 939
2025
Q4 		$978K Buy
+28,164
New +$994K ﹤0.01% 1008
2024
Q3 		– Sell
-27,139
Closed -$920K – 1255
2024
Q2 		$920K Sell
27,139
-191,753
-88% -$9.78M ﹤0.01% 1062
2024
Q1 		$14.2M Buy
218,892
+155,067
+243% +$10.6M 0.05% 407
2023
Q4 		$4.36M Buy
63,825
+9,732
+18% +$506K 0.02% 656
2023
Q3 		$2.81M Sell
54,093
-11,767
-18% -$696K 0.01% 826
2023
Q2 		$3.95M Sell
65,860
-383
-0.6% -$21.9K 0.02% 755
2023
Q1 		$3.28M Sell
66,243
-78,491
-54% -$4.41M 0.02% 817
2022
Q4 		$8.26M Buy
144,734
+81,724
+130% +$4.6M 0.05% 488
2022
Q3 		$2.96M Buy
+63,010
New +$3M 0.02% 851

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Voloridge Investment Management's IMCR Position: Q2 2026 in Review

Voloridge Investment Management sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 19,492 shares — an estimated $588K sold.

Voloridge Investment Management first reported a position in IMCR in Q3 2022 and held it in 10 quarters. The position peaked at $14.2M in Q1 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Voloridge Investment Management reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 19,492 Immunocore shares in Q2 2026, an estimated $588K.
  • Voloridge Investment Management first reported a position in Immunocore in Q3 2022 and held it in 10 quarters.
  • Voloridge Investment Management's Immunocore position peaked at $14.2M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.